• David Crellin

    July 24, 2021 at 3:37 pm

    I read that the Biogen BIIB077 Tofersen trial is being extended to recruit pre-fALS candidates.

    My son who is asymptomatic and carries the c9orf72 mutation is hopeful the same will happen with BIIB078 and Wave WVE-004. If they work, they may offer hope to our families.

Log in to reply.